Is Jazz Pharmaceuticals (JAZZ) Offering An Opportunity After Recent Share Price Pullback [Yahoo! Finance]
Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ)
Last jazz pharmaceuticals plc - ordinary shares earnings: 2/25 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
jazzpharma.com
Company Research
Source: Yahoo! Finance
If you are wondering whether Jazz Pharmaceuticals shares still offer value at current levels, this article walks through what the numbers are really saying about the stock. The share price closed at US$164.49 recently, with a 32.3% return over the past year contrasted with a 5.0% year to date decline. Recent attention on Jazz Pharmaceuticals has centered on company specific developments and sector sentiment in pharmaceuticals and biotech. These factors have helped frame how investors view the balance between its longer term share price gains and the shorter term pullback. On Simply Wall St's valuation checks, Jazz Pharmaceuticals records a value score of . Next, we will walk through the methods behind that score, then finish with a way to look beyond the standard models to judge whether that value story really fits you. Jazz Pharmaceuticals delivered 32.3% returns over the last year. See how this stacks up to the rest of the Pharmaceuticals industry. A Discounted Cash Flow,
Show less
Read more
Impact Snapshot
Event Time:
JAZZ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JAZZ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JAZZ alerts
High impacting Jazz Pharmaceuticals plc - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
JAZZ
News
- Truist Securities Raises Jazz Pharmaceuticals (JAZZ) Price Target After HERIZON-GEA Trial [Yahoo! Finance]Yahoo! Finance
- Jazz Pharmaceuticals (NASDAQ:JAZZ) had its "buy" rating reaffirmed by analysts at TD Cowen.MarketBeat
- Jazz Pharmaceuticals (JAZZ) Is Up 5.1% After Monetizing FDA Voucher And Expanding Oncology Collaboration [Yahoo! Finance]Yahoo! Finance
- Jazz Pharmaceuticals price target raised to $235 from $210 at Needham [Yahoo! Finance]Yahoo! Finance
- Jazz Pharmaceuticals (NASDAQ:JAZZ) had its price target raised by analysts at Truist Financial Corporation from $220.00 to $230.00. They now have a "buy" rating on the stock.MarketBeat
JAZZ
Earnings
- 11/5/25 - Beat
JAZZ
Sec Filings
- 1/21/26 - Form 4
- 1/21/26 - Form 4
- 1/21/26 - Form 4
- JAZZ's page on the SEC website